A 35-year-old Indian man with systemic lupus erythematosus (SLE) presents with recurrent Neisseria meningitidis meningitis. His complement studies show persistently low C3 and C4 levels. A serum complement hemolytic assay (CH50) is performed and found to be markedly reduced. Which component of the complement cascade is most likely deficient in this patient?

Explanation

## Clinical Context: SLE with Recurrent Meningococcal Infection ### Interpreting the Clinical Clues **Key Point:** This patient has two important findings: 1. **Persistently low C3 and C4** — pointing to classical pathway activation/consumption (as seen in SLE) 2. **Recurrent Neisseria meningitidis meningitis** — pointing to a defect in opsonization or MAC formation The question asks which **single complement component** is most likely deficient given **both** low C3 AND low C4 AND markedly reduced CH50 AND recurrent meningococcal disease. ### Why C3 Deficiency is the Best Answer **C3 is the central hub of the complement system.** It is required for: - Amplification of both classical and alternative pathways - Opsonization (C3b deposition) - Formation of the C5 convertase → MAC (C5b-9) | Feature | C3 Deficiency | Terminal Deficiency (C5-C9) | C1q Deficiency | |---------|--------------|----------------------------|----------------| | **C3 level** | **Low** | Normal | Low (secondary) | | **C4 level** | Low (secondary) | Normal | **Low** | | **CH50** | Markedly reduced | Markedly reduced | Markedly reduced | | **Recurrent Neisseria** | Yes | Yes | Less prominent | | **SLE association** | Strong | Weak | Strong (C1q) | | **Encapsulated organism infections** | Yes | No | Yes | **High-Yield:** C3 deficiency causes **both** low C3 and low C4 (because without C3, the feedback amplification loop fails and C4 is consumed without regeneration of downstream components). It also causes susceptibility to **encapsulated organisms including Neisseria** due to impaired opsonization and absent MAC formation. ### Understanding CH50 in C3 Deficiency ``` CH50 Assay: Requires intact classical pathway C1q → C4 → C2 → C3 → C5-C9 If C3 is absent → C5 convertase cannot form → MAC cannot assemble → NO lysis → CH50 = 0 (markedly reduced) ``` **Clinical Pearl (Harrison's Principles of Internal Medicine):** C3 deficiency is the most severe complement deficiency, presenting with recurrent infections with encapsulated bacteria (including *Neisseria meningitidis*, *Streptococcus pneumoniae*, *Haemophilus influenzae*), immune complex disease (SLE-like), and markedly reduced CH50. Both C3 and C4 are low because immune complexes drive classical pathway consumption, and C3 deficiency prevents normal complement turnover. ### Why Not the Other Options? - **C8 deficiency (A):** Terminal component deficiency — C3 and C4 would be **normal** (not low). CH50 reduced, but C3/C4 normal. Does NOT explain persistently low C3 and C4. - **C1q deficiency (B):** Would cause low C4 (classical pathway blocked early), but C3 would be **normal or only mildly reduced** since alternative pathway can still activate C3. Also, C1q deficiency is strongly associated with SLE but NOT specifically with recurrent meningococcal disease. - **C5 deficiency (C):** Terminal component — C3 and C4 would be **normal**. Does NOT explain persistently low C3 and C4. ### Pathophysiology Summary 1. C3 deficiency → failure of opsonization AND failure to form C5 convertase 2. No C5 convertase → no MAC (C5b-9) → Neisseria survives → recurrent meningitis 3. Immune complex accumulation (no C3b-mediated clearance) → SLE-like disease 4. Both C3 and C4 are low due to ongoing classical pathway activation without efficient clearance **Mnemonic:** **"C3 = Central 3 functions"** — Opsonization, MAC formation, Immune complex clearance. Deficiency of C3 breaks ALL three. *Reference: Harrison's Principles of Internal Medicine, 21st ed., Chapter on Complement System; Robbins & Cotran Pathologic Basis of Disease, 10th ed.*